• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

34
23
23
23

COUNTRY

23

CATEGORIES

  • 51
  • 15
  • 15
  • 14
  • 9
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

69
75
81
121

PUBLISHED

2
11
31
121

PRODUCT TYPE

80
40
1

Search "Genentech, Inc.-Deals & Alliances Report" returned 121 results.

PRODUCT TITLE
Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] - Product Thumbnail Image

Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

The Pharma and Biotech M&A Trends 2009-2014 report provides comprehensive understanding and unprecedented access to the merger and acquisition agreements entered into by the worlds leading biopharma...

July 2014
FROM

Genentech, Inc. - Strategy and SWOT Report

Genentech, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings...

May 2014
FROM

Genentech, Inc. - Strategic SWOT Analysis Review

Genentech, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT...

January 2014
FROM

Genentech, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain...

June 2014
FROM
Genentech, Inc. (DNA) - Strategic SWOT Analysis Review Genentech, Inc. (DNA) - Strategic SWOT Analysis Review - Product Thumbnail Image

Genentech, Inc. (DNA) - Strategic SWOT Analysis Review

Genentech, Inc. (DNA) - Strategic SWOT Analysis Review Summary Genentech, Inc. (Genentech) is a biotechnology company focused on research and development, manufacture, and marketing of biotherapeutics....

August 2011
FROM

Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines

Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines Summary GBI Research's pharmaceutical research, “Biotech M&A and Licensing...

April 2011
FROM
Cancer Therapies - Global Strategic Business Report Cancer Therapies - Global Strategic Business Report - Product Thumbnail Image

Cancer Therapies - Global Strategic Business Report

This report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy The report provides...

October 2011
FROM
Monoclonal Antibody Based Products - Global Strategic Business Report Monoclonal Antibody Based Products - Global Strategic Business Report - Product Thumbnail Image

Monoclonal Antibody Based Products - Global Strategic Business Report

This report analyzes the worldwide markets for Monoclonal Antibody Based Products in Millions of US$. The major product segments and application areas analyzed are Therapeutics, and Diagnostics, especially...

October 2008
FROM

Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs

“Biomarkers In Drug Discovery - Optimizing Drug Discovery Timeline and Costs” The report provides an in-depth analysis of the potential applications of biomarkers in pharmaceutical drug discovery and...

February 2010
FROM
Galapagos NV - Product Pipeline Review - 2012 Galapagos NV - Product Pipeline Review - 2012 - Product Thumbnail Image

Galapagos NV - Product Pipeline Review - 2012

Galapagos NV – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Galapagos NV - Product Pipeline Review - 2012” provides data on the Galapagos NV’s research and...

October 2012
FROM
Small Molecule Kinase Inhibitors - Global Strategic Business Report Small Molecule Kinase Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Small Molecule Kinase Inhibitors - Global Strategic Business Report

This report analyzes the Global Market for Small Molecule Kinase Inhibitors in Millions of US$ by the following Product Segments: Gleevec/Glivec, Tarceva, Sutent, Nexavar, Sprycel, Iressa, Tykerb/Tyverb,...

July 2009
FROM
Rheumatoid Arthritis Therapeutics - Global Strategic Business Report Rheumatoid Arthritis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Rheumatoid Arthritis Therapeutics in US$ Million The report provides separate comprehensive analytics for US, Japan, Europe, Latin America and Rest of...

February 2010
FROM

Innovative R&D Strategies and Models - Outsourcing, Strategic Partnerships and Licensing to Improve Productivity and Contain Costs

“Innovative R&D Strategies and Models - Outsourcing, Strategic Partnerships and Licensing to Improve Productivity and Contain Costs” provides insights into effective innovative strategies adopted by...

September 2011
FROM
Companion Diagnostics - Global Strategic Business Report Companion Diagnostics - Global Strategic Business Report - Product Thumbnail Image

Companion Diagnostics - Global Strategic Business Report

This report analyzes the worldwide markets for Companion Diagnostics in US$ Thousand The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World Annual estimates...

September 2011
FROM
Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerging Markets and Impact on ROI Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerging Markets and Impact on ROI - Product Thumbnail Image

Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerging Markets and Impact on ROI

Offshoring and outsourcing have become an increasingly critical contributor to pharma and biotech R&D strategies in recent years They enable companies to focus on core competencies such as drug discovery...

March 2009
FROM

Metastatic Melanoma - Pipeline Review, H2 2013

Global Markets Direct's, 'Metastatic Melanoma - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development...

September 2013
FROM
Antibiotics Partnering Terms and Agreements Antibiotics Partnering Terms and Agreements - Product Thumbnail Image

Antibiotics Partnering Terms and Agreements

The Antibiotics Partnering Agreements report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends...

December 2013
FROM

Colorectal Cancer - Pipeline Review, H1 2013

Colorectal Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Colorectal Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

May 2013
FROM

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2013

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review,...

August 2013
FROM

Skin Cancer - Pipeline Review, H1 2013

Skin Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Skin Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

May 2013
FROM
Loading Indicator